Media coverage
2
Media coverage
Title -BERGENBIO ANNOUNCES FIRST PATIENT DOSED IN PHASE 1B/2A TRIAL EVALUATING BEMCENTINIB IN 1ST LINE NON-SMALL CELL LUNG CANCER WITH STK11 MUTATIONS Media name/outlet M2 PressWIRE Country/Territory United States Date 10/03/23 Persons Rajwanth Veluswamy Title -BERGENBIO ANNOUNCES FIRST PATIENT DOSED IN PHASE 1B/2A TRIAL EVALUATING BEMCENTINIB IN 1ST LINE NON-SMALL CELL LUNG CANCER WITH STK11 MUTATIONS Media name/outlet ENP Newswire Country/Territory United Kingdom Date 10/03/23 Persons Rajwanth Veluswamy